Search Results - "Lin, Vicky Y."
-
1
Inhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21
Published in Cell metabolism (01-07-2008)“…Starvation blocks the actions of growth hormone (GH) and inhibits growth through mechanisms that are not well understood. In this report, we demonstrate that…”
Get full text
Journal Article -
2
Forskolin Stimulates Estrogen Receptor (ER) α Transcriptional Activity and Protects ER from Degradation by Distinct Mechanisms
Published in International journal of endocrinology (09-05-2022)“…Estradiol action is mediated by estrogen receptors (ERs), a and ß. Estradiol binding initiates ER-mediated transcription and ER degradation, the latter of…”
Get full text
Journal Article -
3
FGF21 contributes to neuroendocrine control of female reproduction
Published in Nature medicine (01-09-2013)“…Fibroblast growth factor 21 (FGF21) is a cytokine synthesized and released by the liver, muscle and fat and acts both locally and systemically to regulate…”
Get full text
Journal Article -
4
Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
Published in Molecular cancer therapeutics (01-08-2024)“…We recently reported that resistance to PD-1 blockade in a refractory lung cancer-derived model involved increased collagen deposition and the collagen-binding…”
Get more information
Journal Article -
5
The Fibronectin-ILT3 Interaction Functions as a Stromal Checkpoint that Suppresses Myeloid Cells
Published in Cancer immunology research (01-11-2021)“…Suppressive myeloid cells inhibit antitumor immunity by preventing T-cell responses. Immunoglobulin-like transcript 3 (ILT3; also known as LILRB4) is highly…”
Get more information
Journal Article -
6
ILT2 and ILT4 Drive Myeloid Suppression via Both Overlapping and Distinct Mechanisms
Published in Cancer immunology research (02-05-2024)“…Solid tumors are dense three-dimensional (3D) multicellular structures that enable efficient receptor-ligand trans interactions via close cell-cell contact…”
Get more information
Journal Article -
7
Ligand-Independent Activation of Pituitary ER: Dependence on PKA-Stimulated Pathways
Published in Endocrinology (Philadelphia) (01-08-2001)“…In pituitary and other target tissues, estrogen acts through ERs, which are ligand-activated nuclear transcription factors. ERs can also be activated by…”
Get full text
Journal Article -
8
Truncated Estrogen Receptor Product-1 Stimulates Estrogen Receptor α Transcriptional Activity by Titration of Repressor Proteins
Published in The Journal of biological chemistry (03-10-2003)“…The truncated estrogen receptor product-1 (TERP-1, or TERP) is a pituitary-specific isoform of estrogen receptor α (ERα), and its expression is regulated by…”
Get full text
Journal Article -
9
-
10
Abstract LB156: Preclinical evaluation of NGM707, a novel anti-ILT2/anti-ILT4 dual antagonist monoclonal antibody
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Background: Myeloid immune suppression in the tumor microenvironment is known to contribute to tumor immune evasion. ILT2 (aka LILRB1) and ILT4 (aka LILRB2)…”
Get full text
Journal Article -
11
Abstract LB216: Pre-clinical characterization of NGM831, an ILT3 antagonist antibody for the treatment of solid tumors
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Suppressive myeloid cells inhibit antitumor immunity by preventing T cell responses. Immunoglobulin-like transcript 3 (ILT3, also known as LILRB4) is highly…”
Get full text
Journal Article -
12
Truncated Estrogen Receptor Product-1 Stimulates Estrogen Receptor α Transcriptional Activity by Titration of Repressor Proteins
Published in The Journal of biological chemistry (03-10-2003)“…The truncated estrogen receptor product-1 (TERP-1, or TERP) is a pituitary-specific isoform of estrogen receptor α (ERα), and its expression is regulated by…”
Get full text
Journal Article